# Tolerability Study of Panosyl Isomaltooligosaccharides (PIMO), in Subjects With Chronic Idiopathic Constipation (CIC)

> **NCT05129618** · NA · COMPLETED · sponsor: **Microbiome Health Sciences** · enrollment: 172 (actual)

## Conditions studied

- Constipation Chronic Idiopathic

## Interventions

- **DIETARY_SUPPLEMENT:** MHS 1031
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT05129618
- **Lead sponsor:** Microbiome Health Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-23
- **Primary completion:** 2022-06-12
- **Final completion:** 2022-06-12
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05129618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05129618, "Tolerability Study of Panosyl Isomaltooligosaccharides (PIMO), in Subjects With Chronic Idiopathic Constipation (CIC)". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05129618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*